Regulatory effect of uncarboxylated osteocalcin on osteogenic
and adipogenic differentiation of mouse bone marrow mesenchymal stem cells
under high-glucose conditions

doi:10.3969/j.issn.2095-4344.2032

Abstract

Abstract:

BACKGROUND: The method of promoting osteogenic differentiation of bone marrow mesenchymal stem cells under high-glucose conditions to inhibit adipogenic differentiation can provide prevention and treatment ideas for the treatment of bone metabolic diseases such as diabetic osteoporosis.

OBJECTIVE: To explore the effects of uncarboxylated osteocalcin on adipogenic and osteogenic differentiation of mouse bone marrow mesenchymal stem cells under high-glucose conditions so as to reveal the action mechanism of uncarboxylated osteocalcin on the differentiation of bone marrow mesenchymal stem cells.

METHODS: Mouse bone marrow mesenchymal stem cells were cultured by whole bone marrow culture and adherent purification. Cells were treated with uncarboxylated osteocalcin at different concentrations (0, 1, 3, 10, and 30 μg/L). Cell proliferation was detected by cell counting kit-8 to determine the best mass concentration. Passage 3 bone marrow mesenchymal stem cells were incubated with adipogenic (or osteogenic) differentiation medium, and assigned to four groups: control group, high glucose group, uncarboxylated osteocalcin group, and high glucose + uncarboxylated osteocalcin group. Corresponding groups received the addition of 25.5 mmol/L exogenous glucose and 3 μg/L uncarboxylated osteocalcin. Lipid droplets and calcium nodules were detected by oil red and alizarin red staining. Quantitative reverse transcription-polymerase chain reaction was used to detect the relative expression levels of adipogenic marker genes (Fabp4, PPARγ, Adipsin and FAS) and osteogenic differentiation marker genes (Runx2, Osx, alkaline phosphatase, and type I collagen). Kits were used to detect alkaline phosphatase activity and type I collagen levels. The relative expression levels of P-Erk and P-AMPKα were detected using signal pathway specific inhibitors (PD98059 and BML) and western blot assay.

RESULTS AND CONCLUSION: (1) Uncarboxylated osteocalcin 3 μg/L promoted cell proliferation (P < 0.01). (2) Uncarboxylated osteocalcin promoted the formation of calcium nodules (P < 0.01) in bone marrow mesenchymal stem cells under high-glucose conditions but inhibited the formation of lipid droplets (P < 0.05), down-regulating the relative expression levels of adipogenic marker genes (P_Fabp4 < 0.01; P_PPARγ < 0.05; P_Adipsin < 0.01; P_FAS < 0.01), but increasing the relative expression levels of osteogenic differentiation marker genes (P_Runx2 < 0.05; P_Osx < 0.05; P_ALP < 0.01; P_COLI < 0.01). Uncarboxylated osteocalcin increased alkaline phosphatase activity (P < 0.01) and type I collagen level (P < 0.05). (3) Uncarboxylated osteocalcin up-regulated the expression levels of P-Erk (P < 0.01) and P-AMPKα (P < 0.01) under high-glucose conditions. (4) These results indicate that uncarboxylated osteocalcin promoted osteogenic differentiation of bone marrow mesenchymal stem cells under high-glucose conditions through Erk/AMPKα signaling pathway and inhibited adipogenic differentiation.

Key words: diabetic osteoporosis, bone marrow mesenchymal stem cells, uncarboxylated osteocalcin, adipogenic differentiation, osteogenic differentiation, Erk/AMPKα signaling pathway

CLC Number:

Liu Zhongsheng, Yang Jianhong. Regulatory effect of uncarboxylated osteocalcin on osteogenic and adipogenic differentiation of mouse bone marrow mesenchymal stem cells under high-glucose conditions[J]. Chinese Journal of Tissue Engineering Research, 2020, 24(13): 2039-2046.

Figures/Tables 5

References

[1] YAMAGISHI S, NAKAMURA K, INOUE H. Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients. Med Hypotheses. 2005;65(6):1013-1015.
[2] HOUGH FS, PIERROZ DD, COOPER C, et al. MECHANISMS IN ENDOCRINOLOGY: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus. Eur J Endocrinol. 2016;174(4):R127-138.
[3] 亢晨,张斌,孙瑶.骨代谢紊乱与糖尿病:有价值的防治并举[J].中国组织工程研究, 2014, 18(20): 3263-3266.
[4] MARIA D, SAMSONRAJ RM, MUNMUN F, et al. Biological effects of melatonin on osteoblast/osteoclast cocultures, bone, and quality of life: Implications of a role for MT2 melatonin receptors, MEK1/2, and MEK5 in melatonin-mediated osteoblastogenesis. Journal of Pineal Research. 2018;64(3): e12465.
[5] KHANDUKER S, AHMED R, KHONDKER F, et al. Electrolyte Disturbances in Patients with Diabetes Mellitus. Bangladesh J Med Biochem. 2017;10(1): 27-35.
[6] DIMEGLIO LA, IMEL EA. Calcium and phosphate: hormonal regulation and metabolism. Basic and Applied Bone Biology. 2014:261-282.
[7] PALERMO A, D'ONOFRIO L, BUZZETTI R, et al. Pathophysiology of Bone Fragility in Patients with Diabetes. Calcif Tissue Int. 2017;100(2): 22-132.
[8] NAPOLI N, CHANDRAN M, PIERROZ DD, et al. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 2017; 13(4):208-219.
[9] HARDOUIN P, MARIE PJ, ROSEN CJ. New insights into bone marrow adipocytes: Report from the First European Meeting on Bone Marrow Adiposity (BMA 2015). Bone. 2016;93:212-215.
[10] LI J, ZHANG H, YANG C, et al. An overview of osteocalcin progress. J Bone Miner Metab. 2016;34(4):367-379.
[11] OLDKNOW KJ, MACRAE VE, FARQUHARSON C. Endocrine role of bone: recent and emerging perspectives beyond osteocalcin. J Endocrinol. 2015;225(1):R1-19.
[12] TANGSEEFA P, MARTIN SK, FITTER S, et al. Osteocalcin-dependent regulation of glucose metabolism and fertility: Skeletal implications for the development of insulin resistance. J Cell Physiol. 2018;233(5): 769-3783.
[13] NG KW. Regulation of glucose metabolism and the skeleton. Clin Endocrinol (Oxf). 2011;75(2):147-155.
[14] BONNEAU J, FERLAND G, KARELIS AD, et al. Association between osteocalcin gamma-carboxylation and insulin resistance in overweight and obese postmenopausal women. J Diabetes Complications. 2017; 31(6):1027-1034.
[15] GUEDES JAC, ESTEVES JV, MORAIS MR, et al. Osteocalcin improves insulin resistance and inflammation in obese mice: Participation of white adipose tissue and bone. Bone. 2018;115:68-82.
[16] LIU J, YANG J. Uncarboxylated osteocalcin inhibits high glucose-induced ROS production and stimulates osteoblastic differentiation by preventing the activation of PI3K/Akt in MC3T3-E1 cells. Int J Mol Med. 2016;37(1):173-181.
[17] ZHANG Y, YANG JH. Activation of the PI3K/Akt pathway by oxidative stress mediates high glucose-induced increase of adipogenic differentiation in primary rat osteoblasts. J Cell Biochem. 2013;114(11): 595-2602.
[18] AMBROSI TH, SCIALDONE A, GRAJA A, et al. Adipocyte Accumulation in the Bone Marrow during Obesity and Aging Impairs Stem Cell-Based Hematopoietic and Bone Regeneration. Cell Stem Cell. 2017;20(6):771-784.
[19] MIRANDA C, GINER M, MONTOYA MJ, et al. Influence of high glucose and advanced glycation end-products (ages) levels in human osteoblast-like cells gene expression. BMC Musculoskelet Disord. 2016;17:377.
[20] OKAZAKI R, INOUE D. Mechanism for the Development of Bone Disease in Diabetes: Abnormal Glucose Metabolism. Musculoskeletal Disease Associated with Diabetes Mellitus.2016:43-61.
[21] LIANG Y, LIU Y, LAI W, et al. 1,25-Dihydroxy vitamin D3 treatment attenuates osteopenia, and improves bone muscle quality in Goto-Kakizaki type 2 diabetes model rats. Endocrine. 2019;64(1): 84-195.
[22] WANG C, MENG H, WANG X, et al. Differentiation of Bone Marrow Mesenchymal Stem Cells in Osteoblasts and Adipocytes and its Role in Treatment of Osteoporosis. Med Sci Monit. 2016;22:226-233.
[23] AKABERI S, LINDERGÅRD B, SIMONSEN O, et al. Impact of parathyroid hormone on bone density in long-term renal transplant patients with good graft function. Transplantation. 2006;82(6):749-752.
[24] KANAZAWA I, TANAKA S, SUGIMOTO T. The Association Between Osteocalcin and Chronic Inflammation in Patients with Type 2 Diabetes Mellitus. Calcif Tissue Int. 2018;103(6):599-605.
[25] KIM KM, LIM S, MOON JH, et al. Lower uncarboxylated osteocalcin and higher sclerostin levels are significantly associated with coronary artery disease. Bone. 2016;83:178-183.
[26] XUAN Y, SUN LH, LIU DM, et al. Positive association between serum levels of bone resorption marker CTX and HbA1c in women with normal glucose tolerance. J Clin Endocrinol Metab. 2015;100(1): 74-281.
[27] SHIN DW, KIM SN, LEE SM, et al. (-)-Catechin promotes adipocyte differentiation in human bone marrow mesenchymal stem cells through PPAR gamma transactivation. Biochem Pharmacol. 2009;77(1): 125-133.
[28] SIMANN M, LE BLANC S, SCHNEIDER V, et al. Canonical FGFs Prevent Osteogenic Lineage Commitment and Differentiation of Human Bone Marrow Stromal Cells Via ERK1/2 Signaling. J Cell Biochem. 2017;118(2):263-275.
[29] GU H, HUANG Z, YIN X, et al. Role of c-Jun N-terminal kinase in the osteogenic and adipogenic differentiation of human adipose-derived mesenchymal stem cells. Exp Cell Res. 2015;339(1):112-121.
[30] ABDALLAH BM, ALZAHRANI AM, KASSEM M. Secreted Clusterin protein inhibits osteoblast differentiation of bone marrow mesenchymal stem cells by suppressing ERK1/2 signaling pathway. Bone. 2018;110: 221-229.
[31] KIM H, SAKAMOTO K. (-)-Epigallocatechin gallate suppresses adipocyte differentiation through the MEK/ERK and PI3K/Akt pathways. Cell Biol Int. 2012;36(2):147-153.
[32] WU W, YIN Y, XU K, et al. Knockdown of LGALS12 inhibits porcine adipocyte adipogenesis via PKA-Erk1/2 signaling pathway. Acta Biochim Biophys Sin (Shanghai). 2018;50(10):960-967.
[33] WANG YG, QU XH, YANG Y, et al. AMPK promotes osteogenesis and inhibits adipogenesis through AMPK-Gfi1-OPN axis. Cell Signal. 2016;28(9):1270-1282.
[34] ZENG Y, PU X, YANG J, et al. Preventive and Therapeutic Role of Functional Ingredients of Barley Grass for Chronic Diseases in Human Beings. Oxid Med Cell Longev. 2018;2018:3232080.
[35] MA C, LI G, HE Y, et al. Pronuciferine and nuciferine inhibit lipogenesis in 3T3-L1 adipocytes by activating the AMPK signaling pathway. Life Sci. 2015;136:120-125.
[36] LIU B, YANG T, LUO Y, et al. Oat β-glucan inhibits adipogenesis and hepatic steatosis in high fat diet-induced hyperlipidemic mice via AMPK signaling. Journal of Functional Foods. 2018;41:72-82.